Interest of Medial Partial Arthrodesis in Degenerative and Inflammatory Damage of Lisfranc Tarsometatarsal Joint.

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT04937764

Enrollment

Registered

2021-06-24

Start date

2008-04-08

Completion date

2021-10-30

Last updated

2021-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Arthritis Foot

Brief summary

Research Hypothesis: Lisfranc tarsometatarsal joint arthrodesis is a reliable surgical procedure, allowing the restoration of satisfactory function and a painless foot with an acceptable complication rate. Objective of the study: To analyze the clinical and radiographic results in the medium term of arthrodesis of the Lisfranc tarsometatarsal joint in cases of primary osteoarthritis, post-traumatic osteoarthritis or in cases of inflammatory pathology.

Detailed description

Data collection by return to the patient record: * Clinical score * Analysis of imagery (X-rays, CT scan, ) The patients included were those who had undergone arthrodesis of the medial Lisfranc joint

Interventions

None listed

Study design

Observational model

CASE_ONLY

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* All patients who underwent Lisfranc arthrodesis for primary post-traumatic osteoarthritis or inflammatory disease between January 2008 and December 2020 in * Age \> 18 ans

Exclusion criteria

* Follow-up \< 6 months * Lost to follow-up * lack of data in the patient record.

Design outcomes

Primary

Measure	Time frame	Description
Clinical improvement of the AOFAS score of the midfoot	1 year post surgery	AOFAS Score

Countries

France

Outcome results